Medirom Healthcare Technologies Inc.
corporate_fare Company Profile
Medirom Healthcare Technologies Inc. (NASDAQ:MRM) is a publicly traded company in the Trade & Services sector. Wiseek has independently scored 17 items for MRM at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-18, rated 8/10. Across its 17 most recent items scored 7 or higher, the top rating is 9/10, with 12 rated 8 or above. Recent SEC coverage for MRM spans 6-K, 20-F, SCHEDULE 13D/A.
Recent high-impact activity:
- Medirom Appeals Nasdaq Delisting, Wins 15-Day Trading Stay After Filing Overdue 20-F
- Nasdaq Moves to Delist MEDIROM After Missed Filing Deadline; Appeal Filed
- Medirom Files Long-Delayed 20-F: Going Concern, JPY3.6bn Loss, Nasdaq Delisting Appeal
- Medirom Hit With Second Nasdaq Deficiency — Bid Price Below $1.00
- Medirom Converts ¥275M Bond into Secured Loan, Lifting Total Debt to ¥475M
Financial Snapshot
Short Interest & Short Volume
1.00 days to coverFINRA reported short interest of 9,002 shares in MRM as of the October 30, 2026 settlement, a 69.9% decrease from the prior period — about 1.0 days to cover at its recent average daily volume. On November 20, 2026, 32.2% of MRM volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.
Insider Transactions
MRM files as a Foreign Private Issuer (FPI). Under SEC Exchange Act Section 16(a), officers, directors, and 10% owners of FPIs are exempt from Form 4 insider-transaction reporting requirements. Comparable disclosures, when applicable, appear in the company's Form 20-F (annual) or Form 6-K (interim) filings on SEC EDGAR.